Actively Recruiting
Increasing Access to Fertility Preservation for Women with Breast Cancer
Led by University Paul Sabatier of Toulouse · Updated on 2024-12-12
750
Participants Needed
2
Research Sites
234 weeks
Total Duration
On this page
Sponsors
U
University Paul Sabatier of Toulouse
Lead Sponsor
N
National Cancer Institute, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
The EVAPREF project aims to increase access to fertility preservation by developing an approach to improve and evaluate existing information and coordination tools developed by the Pays-de-la-Loire and Occitanie Regional Cancer networks. First, the investigators will use a qualitative, iterative, user-centered and participatory approach to improve the current tools and create training content for the physicians who will use these tools. Second, the investigators will conduct a randomized stepped wedge trial of women under 40 newly treated with chemotherapy for breast cancer. The investigators will evaluate the rate of fertility preservation consultation before and after implementation of the improved tools, over a 30-month period from mid-2023 to the end of 2025. Finally, in a third step, the investigators will study their approach (context-sensitive implementation analysis) and provide key elements for its transferability to other contexts and in particular to other Regional Cancer networks in France.
CONDITIONS
Official Title
Increasing Access to Fertility Preservation for Women with Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 and under 40 years of age treated for newly diagnosed breast cancer and receiving chemotherapy.
- Able to read the study information poster and fertility preservation brochure in French, alone or with help from a caregiver, relative, or interpreter.
- People with intellectual disability can participate if able to read the study information and brochure in French, alone or with help.
You will not qualify if you...
- People whose mental health status precludes participation in the study, as determined by the clinical team.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
CHU Nantes
Nantes, France
Actively Recruiting
2
Institut Claudius Regaud (IUCT-O)
Toulouse, France
Actively Recruiting
Research Team
M
Marie-Anne Durand, PhD
CONTACT
S
Sébastien Lamy, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here